One Large New Zealand Hospital Has Chosen Bioquell to Combat COVID-19

One of New Zealand’s largest hospitals has chosen to purchase their first Bioquell BQ-50 suite to help them combat COVID-19. The hospital is well versed in performing airborne disinfection with alternative technologies but has selected Bioquell to improve their decontamination capabilities.  The Bioquell BQ-50 has been chosen due to its emphasis on operator and patient safety, backed by extensive independently published data that supports the use of the technology against a wide range of challenging organisms. Biodecon Solutions – Bioquell’s Australasian distribution partner – is vastly experienced in rolling out Bioquell technology in the healthcare setting and will play a vital role in the quick establishment of this technology in the hospital’s fight against COVID-19.

The Bioquell BQ-50 is a mobile and robust Hydrogen Peroxide Vapor generator that can be used hospital-wide to eliminate nosocomial pathogens. It is simple, automatic and easy to use, making it ideal for healthcare environments.